Alternative Cancer Treatment Information, specific anticancer drugs, and drug development and approval. Research updates, cancer treatment facilities.

The Vitamin C Cure for Cancer Dr. Mort Walker

The Vitamin C   Cure for Cancer   Dr. Mort Walker

Practitioners of conventional oncology (tumor) medicine have overlooked  a

particularly important medical journal article about using therapeutic nutrition against
cancer. They have ignored this vital piece of information simply because when it
appeared, it did so ’way in the back pages
of a major medical journal. Before my
bringing the article to your attention here, it stayed unnoticed by both cancer therapists
and cancer victims.
In the current published piece, the medical scientists, all specialists in oncological
nutrition, clearly state: “Our findings give plausibility to the use of intravenous ascorbic
acid (IV vitamin C) for cancer treatment.”
I urge you to look up the article footnoted at the end of this Special Report. But if
the reference (footnote No. 1) is unavailable to
you, you will find its full text, along with
other published papers advocating IV vita
min C as anticancer therapy, listed and
accessible to you at no charge on the Internet. Simply go to
Renowned orthomolecular medical res
earchers of
previous years, including two-time
Nobel Laureate Linus Pauling, Ph.D., were right when they announced their original
findings in 1979. Despite being ridiculed
and called “quacks,” these orthomolecular
medicine investigators had long recognized the great importance of vitamin C in fighting
Dr. Pauling defined orthomolecular
medicine as “the treatment of disease by the
provision of the optimum molecu
lar environment, especially
the optimum concentrations
of substances normally present in the human body.” Orthomolecular medicine uses safe,effectiveTherapy to fight illness. Almost every one of the nutrients it uses is safe, natural, and nontoxic.
Dr. Pauling wrote forewords to two of my 83 published books. I co-authored one with Abram Hoffer, M.D., Ph.D., under the title:Orthomolecular Nutrition: New Lifestyle for Super Good Health (Keats Publishing, 1978). It was reissued 20 years later by The McGraw-Hill Companies with new, updated information at $17.95  This second edition McGraw-Hill book’s title is Putting It All Together: The New Orthomolecular Nutrition.) All of the enlightened orthomolecular physicians originally received traditional training in prescribing drugs, but eventually they realized that using products that the pharmaceutical industry manufactured did not bring their patients to a state of permanentwellness.
Drugs are only stopgaps for crises; in contrast, orthomolecular remedies such as intravenous ascorbic acid keep a person out of the hospital and prevent the steady deterioration of his or her physiology. Today’s nutrition-oriented doctors have become full-time practitioners of the new branch of medical therapy called“holistic medicine.”
One dispenser of holistic medicine is Leonard Haimes, M.D., who has been offering his patients preventive medical health care for more than 51 years. Dr. Haimes is medical director of the Haimes Centre Clinic, 7300 North Federal Highway, Suite 100,Boca Raton, Florida 33487. His medical practice partner is Mitchell F. Matez, D.O.;their office telephone is (561) 995-8484; their FAX is (561) 995-7773.Patients arrive at Boca Raton’s Haimes Centre Clinic from  all over Florida and other southern states to receive large doses of intravenous vitamin C—even as high as 150 grams per IV infusion. It is unlikely that people would take in anywhere near this dosageorally, because taking such a concentration of vitamin C by mouth will almost certainly cause an intolerable gastrointestinal reaction in the form of excessive diarrhea.
How Intravenous Vitamin C Kills Cancer
At very high levels in your blood, vita
min C acts against malignancies within the
body, or even externally in test tubes or Petri dishes, as a pro-oxidant. This oxygen-
attracting character
istic of the vitamin makes it an
effective killer of cancer cells.
Malignant cells cannot survive in the presence of oxygen molecules.
I want to emphasize, therefore, that
ascorbic acid (vitamin C) that is in touch with
cancer cells, whether in cultures (in vitro) or in the animal or human body (in vivo), kills
cancer cells without harming normal cells. It
does this by generating hydrogen peroxide,
a potent oxidant, directly within the cancer
tissues, and no damage happens to the
surrounding, normal tissues. Cancer’s physiology (the metabolism of cancer cells)
regards the pro-oxidant quality
of high-concentration vitamin C as deadly poison!4
You can find confirmation of the paragraph above in another published paper that six
orthomolecular physicians of great eminence
collaborated on. These six doctors are
Sebastian J. Padayatty, M.D.; Hugh D. Rior
dan, M.D.; Stephen M. Hewitt, M.D.; Arie
Katz, M.D.; L. John Hoffer, M.D.; and Mark Levine, M.D.
These holistic oncological physicians represent medical institutions of exceptional
distinction such as the Molecular and Clinical
Nutrition Section of the Digestive Diseases
Branch of the National Institute of Diabetes and Digestive and Kidney Diseases (Drs.
Padayatty, Katz, Levine); the Laboratory of Pathology, Centers for Cancer Research,
National Cancer Institute (Dr.
Hewitt); National In
stitutes of Health, Bethesda, Maryland;
Lady Davis Insititute for Medical Research (D
r. Hoffer) at McGill University, Montreal,
Quebec, Canada.; the Bio-Communications Res
earch Institute (Dr. Riordan, who died
while I was just beginning my research for th
is present Special Report), Wichita, Kansas.
Please send requests for further clarification of the six scientists’ conclusions to Dr.
Mark Levine, Molecular and Clinical Nutrition Section, Building 10, Room 4D52-MSC
1372, National Institutes of Health, Bethesda, MD 20892-1372; e-mail:
IV administration of the maximum tolerated dose of vitamin C produces blood
plasma levels 25 times what people achieve wh
en they take the same dose orally. At
high plasma concentrations, absorbic acid is toxic to most cancers, and the six
orthomolecularists illustrate their conclusions with three published abstracts of case
histories describing patients’ su
ccesses against cancer disabilities
Case History One: Bladder Cancer
Arthur Compton (pseudonym), age 49, consulted his urologist because blood was
steadily showing in his urine (hematuria). Cystoscopic examination showed that he had a
primary bladder tumor with
multiple satellite tumors extending two to three cm around
it. He underwent surgery. Doctors did transurethral resection of the primary tumor and
its surrounding tumor satellites, and fulgurated (cauterized) their bases.
Mr. Compton declined chemotherapy or radiotherapy and instead chose to receive 30
g of intravenous vitamin C twice weekly for three months. When these infusions ended,
he started receiving 30 g of the same nutrient once every one to two months for four
years. At the same time, the monthly IV inj
ections were in
terspersed within periods of
one to two months with frequent ascorbic acid infusions.
In March, 2006, nine years afte
r his diagnosis, Mr. Compton remained in good
health, with no symptoms of recurrence or me
tastasis. He maintained his vigorous health
by taking the following oral nutritional supplements: botanical extract, chondroitin
sulfate, chromium picolinate, flax oil, gluc
osamine sulfate, alpha-l
ipoic acid, selenium,
and two probiotic bacteria, Lactobacillus acidophilus plus L. rhamnosus

Case History Two: Lymphoma
Doctors found that 66-year-old homemak
er Margaret C. Warner (pseudonym) had a
large paraspinal malignant
mass on the left side of her iliopsoas muscle (located
internally to her back muscles
at the level of her forth and fifth lumbar vertebrae). The
mass measured 3.5 to 7 cm across and 11 cm in the craniocaudal direction, with
extension into the posterior paraspinal muscle
. The mass had invaded her spine as well.
Biopsy revealed a diffuse, large B-cell lymphoma, and her oncologist recommended that
Mrs. Warner undergo a five-week course of radiation and chemotherapy. She refused the
chemo but took radiation, along with IV vitamin C.
Mrs. Warner received 15 g of vitamin C twice per week for two months, 15 g once to
twice per week for seven months, and then one g of IV vitamin C once every two to three
months for one year, starting in January, 1995
, along with the radiation therapy.
New right and left axillary lymph nodes popped up during the radiations, but when
those treatments ended in mid-March, 1995, the lymph problem disappeared. She
continued with her IV vitamin C injections
. During the following months, lymph node
enlargements appeared and disappeared on a regular basis till December, 1996, when the
oncologist re-examined Mrs. Warner thoroughly a
nd declared her to be in normal health,
with no clinical sign of lymphoma.
Ten years after the diagnosis of diffuse large B-cell lymphoma at stage III, she is
unaffected in any way by the previous cancer. Today Margaret Warner uses additional
nutritional supplements in the form of beta-carotene, bioflavonoids, chondroitin sulfate,
coenzyme Q-10, dehydroepiandrosterone, N-acetylcysteine, a multiple vitamin
supplement, a botanical supplem
ent, and bismuth tablets.
Case History Three: Kidney Cancer
At age 51, Laura Sacks (pseudonym) was found in August, 1995, to have a
malignant tumor involving her left kidney.
Nephrectomy (kidney removal) in September,
1995, proved she had renal cell carcinoma (ki
dney cancer), 9 cm in diameter, with a
thrombus (blood clot) extending into the renal vein. Abdominal Cat scans and chest x-
ray films showed no sign of
metastatic disease (i.e., it
had not spread elsewhere).
By March, 1996, further diagnostic work showed that new, small, rounded soft-tissue
masses pointed to Mrs. Sacks having metastatic cancer, and by November, 1996, chest
radiography revealed the spreading of small but multiple cannonball-like lesions
(damage). Her conventional oncologists urged
her to receive radiation therapy and/or
She declined conventional cancer treatment and instead chose to receive high
concentrations of vitamin C intravenously at a dosage of 65 g (grams) twice per week for
10 months, starting in October, 1996. She also used other alternative therapies, i.e.,

thymus protein extract, N-acetylcysteine, ni
acinamide, and whole thyroid extract.
Amazingly, in June, 1997, her chest radiography showed her to be clear of cancerous
lesions. They had vanished, except for one a
bnormality in the left lung field that her
doctor thought might merely be a pulmonary scar from some former trauma.
She had long since stopped her high-dose vitamin C infusions when in October,
2001, her doctor spotted a new mass 3.5 cm in
diameter in her anterior right lung via
radiography. A biopsy revealed small-cell carcinoma of the lung and she started
receiving IV vitamin C again. This new cancer was more aggressive and caused
abdominal distension and constipation. By Oc
tober, 2002, the patient had died, with no
autopsy being performed. Local pathologists
concluded that Laura Sacks had died from
small-cell lung cancer, not any recurrence of he
r original metastatic renal cell carcinoma.
It would be fair to wonder whethe
r continued high-dose IV
vitamin C would have
kept her from being affected by lung
cancer, because her renal cell carcinoma had
disappeared due to her vitamin C infusions. Later, Mrs. Sacks’ close relatives revealed to
the six orthomolecular physicians that she was a longstanding cigarette smoker, and
smoked even while receiving treatment for the kidney cancer.
More on How Intravenous C Works
Reported in accordance with the Best Case Series process of the National Cancer
Institute, the content of this Special Report shows that ascorbic acid given intravenously
as a cancer therapy has the potential to cure cancer.
Patients who consume tightly cont
rolled plasma and cell concentrations in the
amount of 200 to 300 mg per day of vitamin C in five or more daily servings of fruits and
vegetables show fasting steady-state plasma
concentrations of only about 70-80 mini-
mol/L of the vitamin. In contrast, peak pl
asma concentrations of vitamin C obtained
intravenously tend to reach 14,000 mini-mol/L in patients’ blood, which selectively kills
cancer cells but not normal cells.
The sole cause of the cancer cells’
death is extracellular ascorbate, at pharmacologic
concentrations that patients can achieve only
intravenously. IV ascorbic acid generates
hydrogen peroxide in the blood, which serves as a naturally induced pro-drug (a good
thing), rather than the artificial, toxicologi
cal negative effect of laboratory-manufactured
chemical drugs.4
References for this Special Report
1. Chen, Q.; Espey, M.G.; Krishna, M.C.; Mitchell, J.B.; Corpe, C.P.; Buettner,
G.R.; Shacter, E.; Levine, M. “Pharmacologi
c ascorbic acid concentrations selectively
kill cancer cells: Action as a
pro-drug to deliver hydroge
n peroxide to tissues.”
Proceedings of the National Academy of Sciences
, USA. 2005 Sep. 20;102(38):13604-
13609.Sep. 12, 1005.
By reading these special reports you are demonstrating an interest in maintaining good and
vigorous health.
These reports suggest ways you can do that, but — as with anything in medicine — there are no
You must check with private, professional medical advisors to assess whether the suggestions in
these reports are appropriate for you. And please note, the contents of these reports may be
considered controversial by the medical community at large.
The authors, editors and publishers of these reports are not doctors or professional health
caregivers. They have relied on information from people who are. The information in these
reports is not meant to replace the attention or advice of physicians or other healthcare
professionals. Nothing contained in these reports is meant to constitute personal medical advice
for any particular individual.
Every reader who wishes to begin any dietary, drug, exercise or other lifestyle changes intended
to treat a specific disease or health condition should first get the advice of a qualified health care
No alternative OR mainstream cancer treatment can boast a one hundred percent record of
success. Far from it. There is ALWAYS some risk involved in any cancer treatment. The authors,
editors, and publishers of these reports are not responsible for any adverse effects or results from
the use of any of the suggestions, preparations or procedures described in the reports. As with any
medical treatment, results of the treatments described in these reports will vary from one person
to another.
The authors report here the results of a vast array of treatments and research as well as the
personal experiences of individual patients, healthcare professionals and caregivers. In many
cases the authors were not present themselves to witness the events described, but relied in good
faith on the accounts of the people who were.
© Copyright 2009 by Online Publishing & Marketing, LLC, PO Box 1076, Lexington, VA 2445



No Comments Yet

Leave a Reply